Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Speaker
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
W
Wachtel, Heather
University of Pennsylvania
Endocrine/ Head & Neck Poster Presentations 1
Location:SSO HUB: Breast & Endocrine Zone
Heather Wachtel
P23: Resection of the Primary Tumor Improves Survival in Metastatic Adrenocortical Carcinoma
Location:SSO HUB: Breast & Endocrine Zone
Heather Wachtel
P25: What are the clinical implications of SDHA pathogenic variants?
Location:SSO HUB: Breast & Endocrine Zone
Heather Wachtel
Questions and Discussion
Location:Ballroom C
Heather Wachtel
Surgical Considerations for Adrenal Metastasectomy
Location:Ballroom C
Heather Wachtel
Wada, David
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA
57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations
Location:Veterans Memorial Auditorium
David Wada
Wadwah, Anupama
UTSW
72: Cost Analysis and Financial Implications of Cytoreductive Surgery and HIPEC: a US Single Center Experience
Location:Ballroom B
Anupama Wadwah
Wagner, Andrew
Dana-Farber Cancer Institute
Case Presentation and Discussion
Location:Ballroom A
Andrew Wagner
Wagner, Patrick
Allegheny Health Network
65: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH Sensitive Imaging Agent: Topline Results from a Phase 2 Study
Location:Veterans Memorial Auditorium
Patrick Wagner
69: Peritoneal fluid cytokine analysis reveals targets for regional immunotherapy in carcinomatosis
Location:Ballroom B
Patrick Wagner
P55: Defining Values and Quality of Life of Cancer Survivors following Cytoreductive Surgery and HIPEC: An International Study
Location:SSO HUB: Rare/Metastatic Cancers Zone
Patrick Wagner
Wainaina, Njeri
Medical College of Wisconsin, Department of Internal Medicine
87: Identifying Optimal Surgical Timing Relative to SARS-CoV-2 Infection Using COVID-19 Severity in Cancer Patients
Location:Ballroom B
Njeri Wainaina
Wainstein, Alberto
COP, FHEMIG
Case Presentation and Discussion
Location:Ballroom A
Alberto Wainstein
Wajih, Nadeem
Wake Forest University
66: Utilizing Organoids to Study Perfusate Selection in Appendiceal Cancer Patients Undergoing Repeat HIPEC
Location:Ballroom B
Nadeem Wajih
68: Assessing the Mucolytic and Cytotoxic Activity of Bromelain in Appendiceal Cancer Organoids
Location:Ballroom B
Nadeem Wajih
Waks, Adrienne
Harvard Medical School Dana-Farber Cancer Institute
PeerView Independent Satellite Symposium: Navigating Complex Decisions at the Intersection of Local and Systemic Management of Early Breast Cancer
Location:Room 304
Adrienne Waks
Walch, Henry
Memorial Sloan Kettering Cancer Center
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
Henry Walch
Walt, Matthew
Coriell Institute for Medical Research
10: Epigenetic Drug Therapy Increases Immune Activation and Expression of Genes in the Oncotype Dx Score in Breast Cancer
Location:Veterans Memorial Auditorium
Matthew Walt
Wang, Hannah
Atrium Health Carolinas Medical Center
47: Surgical Microwave Ablation for Treatment of Hepatocellular Carcinoma: A Single Institution Review from 2006-2022
Location:Ballroom A
Hannah Wang
Wang, Hui
University of North Carolina
29: Development of a novel PET agent for parathyroid imaging targeting the Calcium-Sensing Receptor (CaSR)
Location:Ballroom A
Hui Wang
Wang, Laura
University of Pennsylvania
75: T cell Inducible Costimulator (ICOS) blockade increases the efficacy of imatinib in Gastrointestinal Stromal Tumor (GIST)
Location:Ballroom A
Laura Wang
91: CD40 activation has direct tumor effects in gastrointestinal stromal tumor (GIST)
Location:Ballroom A
Laura Wang
Wang, Sam
UT Southwestern Medical Center
72: Cost Analysis and Financial Implications of Cytoreductive Surgery and HIPEC: a US Single Center Experience
Location:Ballroom B
Sam Wang
96: Serum IL-6 level predicts survival and treatment response in gastric and gastroesophageal junction cancer
Location:Ballroom A
Sam Wang
Wang, Ton
Cedars-Sinai Medical Center
18: Clinical Impact of Semi-Annual Mammography in Patients Undergoing Breast Conserving Surgery Following Neoadjuvant Therapy
Location:Veterans Memorial Auditorium
Ton Wang
Wang, Tracy
Medical College of Wisconsin
P22: Adoption of Robotic Adrenalectomy is Associated with a Short Learning Curve and Improved Outcomes
Location:SSO HUB: Breast & Endocrine Zone
Tracy Wang
Wang, Wenjia
University of Rochester Medical Center
P34: Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Wenjia Wang
Wang, Yu
The Ohio State University, Tongji Hospital, Huazhong University of Science and Technology
P57: Phosphorylation of IWS1 by AKT Maintains Liposarcoma Tumor Heterogeneity through Preservation of Cancer Stem Cell Phenotypes and Mesenchymal-Epithelial Plasticity
Location:SSO HUB: Melanoma & Sarcoma Zone
Yu Wang
Wani, Khalida
MD Anderson Cancer Center
95: Cancer Testis Antigen and Interleukin Expression Correlates with Survival in Small Bowel Neuroendocrine Tumors
Location:Ballroom A
Khalida Wani
Wapnir, Irene
Standford University School of Medicine
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Irene Wapnir
Wargo, Jen
The University of Texas MD Anderson Cancer Center
95: Cancer Testis Antigen and Interleukin Expression Correlates with Survival in Small Bowel Neuroendocrine Tumors
Location:Ballroom A
Jen Wargo
PeerView Independent Satellite Symposium: Harnessing the Power of Immunotherapy in Resectable Melanoma: Guidance for Delivering Effective Adjuvant and Neoadjuvant Strategies
Location:Room 302
Jen Wargo
Warner, Susanne
Mayo Clinic
51: Response to neoadjuvant chemotherapy in invasive intraductal papillary mucinous cystic neoplasm compared to de novo pancreatic ductal adenocarcinoma
Location:Ballroom A
Susanne Warner
70: Oncologic outcomes of cytoreductive surgery and HIPEC for highly selected patients with pancreatic ductal adenocarcinoma
Location:Ballroom B
Susanne Warner
P31: Accuracy of DOTATATE PET/CT in the Preoperative Planning of Small Bowel Neuroendocrine Tumor Resection
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Susanne Warner
Warren, Emilie
Winship Cancer Institute, Emory University
26: Neoadjuvant Chemoradiation Does Not Improve Outcomes for Patients Undergoing Resection for Upper Rectal Cancer: A US Rectal Cancer Consortium Analysis
Location:Ballroom C
Emilie Warren
Wasif, Nabil
Mayo Clinic Arizona
P63: Is there a benefit to radiation and surgery in specific histologic subtypes of retroperitoneal sarcoma?
Location:SSO HUB: Melanoma & Sarcoma Zone
Nabil Wasif
Weber, Jeffrey
NYU Langone Medical Center
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Jeffrey Weber
Weber, Sharon
UW Health/UW Madison
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Sharon Weber
Plenary Session 1
Location:Veterans Memorial Auditorium
Sharon Weber
Welcome to SSO 2023
Location:Veterans Memorial Auditorium
Sharon Weber
Weber, Walter
Department of chest, abdomen and pelvis University hospital Basel, Basel, Switzerland
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Walter Weber
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Walter Weber
Weed, Christina
Cedars-Sinai Medical Center
18: Clinical Impact of Semi-Annual Mammography in Patients Undergoing Breast Conserving Surgery Following Neoadjuvant Therapy
Location:Veterans Memorial Auditorium
Christina Weed
Weerasinghe, Roshanthi
Providence Saint John's Cancer Institute
81: Racial and socioeconomic disparities in colorectal cancer screening during the COVID-19 pandemic
Location:Ballroom B
Roshanthi Weerasinghe
Wei, Alice
Memorial Sloan Kettering Cancer Center
27: The Prognostic Value of Pre- and Post-Neoadjuvant Chemotherapy Serum Carcinoembryonic Antigen Levels in Patients Having Resection of Colorectal Liver Metastases
Location:Ballroom C
Alice Wei
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
Alice Wei
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
Alice Wei
Pro
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Alice Wei
Wei, Iris
Memorial Sloan Kettering Cancer Center
ERAS Colorectal Surgery Update: Is Same Day Colectomy Ready for Primetime?
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Iris Wei
P20: Microsatellite Instability (MSI): The Transition from Favorable to Unfavorable Outcomes with Lymph Node Metastases
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Iris Wei
Weiser, Martin
Memorial Sloan Kettering Cancer Center
Immunotherapy for MMR-D Rectal Cancer
Location:Ballroom B
Martin Weiser
P20: Microsatellite Instability (MSI): The Transition from Favorable to Unfavorable Outcomes with Lymph Node Metastases
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Martin Weiser
Questions and Discussions
Location:Ballroom B
Martin Weiser
Weiser, Roi
University of Texas Medical Branch
8: De-escalation of Post-Mastectomy Irradiation in Hormone Receptor-Positive Breast Cancer with One to Three Positive Nodes
Location:Veterans Memorial Auditorium
Roi Weiser
Weiss, Anna
Brigham and Women's Hospital
4: Germline Genetic Mutations in a Prospective Multi-Center Cohort of 241 Phyllodes Tumors; Time to Expand Testing Criteria
Location:Veterans Memorial Auditorium
Anna Weiss
Weiss, Jessica
Providence Saint John's Cancer Institute
81: Racial and socioeconomic disparities in colorectal cancer screening during the COVID-19 pandemic
Location:Ballroom B
Jessica Weiss
Weiss, Matt
Northwell Health
JHU Trial on Whipple Wound Vac
Location:SSO HUB: Immuno-Oncology Zone
Matt Weiss
Strategies to Reduce Surgical Site Infections
Location:SSO HUB: Immuno-Oncology Zone
Matt Weiss
Wells-DiGregorio, Sharla
The Ohio State University Wexner Medical Center
P76: Surgeon Perspectives on Management of Aborted Cancer Surgery: Results of an SSO Member Survey
Location:SSO HUB: Rare/Metastatic Cancers Zone
Sharla Wells-DiGregorio
Wendt, Staci
Providence Saint John's Cancer Institute
81: Racial and socioeconomic disparities in colorectal cancer screening during the COVID-19 pandemic
Location:Ballroom B
Staci Wendt
Wen, Duan
University of California Los Angeles
P43: Prognostic assessment of sentinel lymph node metastases: Are we using the wrong measure of tumor burden?
Location:SSO HUB: Melanoma & Sarcoma Zone
Duan Wen
Wen, Jing
The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute
67: Molecular mechanism of colorectal peritoneal metastasis: an interesting TWIST
Location:Ballroom B
Jing Wen
Wenzel, Alexander
UC San Diego
76: Single nuclei RNAseq Reveals Dedifferentiation States from Human ICCs to GIST
Location:Ballroom A
Alexander Wenzel
Westin, Shannon
MD Anderson Cancer Center
65: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH Sensitive Imaging Agent: Topline Results from a Phase 2 Study
Location:Veterans Memorial Auditorium
Shannon Westin
West, Junior
Department of Cell Biology, School of Medicine, Johns Hopkins University
71: Intra-and interpatient drug response heterogeneity exist in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastrointestinal cancers
Location:Ballroom B
Junior West
Whelan, Richard
Northwell Health
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Richard Whelan
White, Nicole
Washington University in St. Louis
22: The Long non-coding RNA RAMS11 Promotes Chemotherapy Resistance in-vivo in Metastatic Colorectal Cancer.
Location:Ballroom C
Nicole White
White, Richard
Atrium Health-Levine Cancer Institute
7: Multicenter clinical trial for omission of breast surgery in invasive cancer following neoadjuvant systemic therapy: Longitudinal patient reported outcomes and decisional comfort planned analyses
Location:Veterans Memorial Auditorium
Richard White
Widmar, Maria
Department of Surgery, Memorial Sloan Kettering Cancer Center
P20: Microsatellite Instability (MSI): The Transition from Favorable to Unfavorable Outcomes with Lymph Node Metastases
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Maria Widmar
Wiechmann, Lisa
Columbia University Medical Center
P2: Incidence of lymph node involvement in clinically node-negative breast cancer patients following neoadjuvant chemotherapy and identification of clinicopathologic features which may lead to omission of sentinel lymph node biopsy
Location:SSO HUB: Breast & Endocrine Zone
Lisa Wiechmann
Wilhelm, Scott
Division of Surgical Oncology, University Hospitals Cleveland Medical Center
P26: Applying 8th edition AJCC guidelines to differentiated thyroid cancer: Stage migration and impact on overall survival
Location:SSO HUB: Breast & Endocrine Zone
Scott Wilhelm
Williams, Austin
Fox Chase Cancer Center
14: Should patients with HR+HER2- breast cancer and 1-3 positive sentinel nodes undergo axillary dissection to determine candidacy for abemaciclib?
Location:Veterans Memorial Auditorium
Austin Williams
Breast Poster Presentations 3
Location:SSO HUB: Breast & Endocrine Zone
Austin Williams
Williams, Richelle
University of Maryland School of Medicine
Optimal Method of Reconstruction after Gastrectomy
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Richelle Williams
Upper GI Poster Presentations 1
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Richelle Williams
Willis, Alliric
Sidney Kimmel Medical College, Thomas Jefferson University
Careers in DEI/Disparities Research for Surgical Oncologists
Location:Ballroom C
Alliric Willis
Strategies to Increase Enrollment of Diverse Populations in Clinical Trials
Location:SSO HUB: Rare/Metastatic Cancers Zone
Alliric Willis
Willmon, Parker
Vanderbilt University
P21: Utility of near infrared autofluorescence detection of small bowel neuroendocrine tumors to guide extent of resection
Location:SSO HUB: Breast & Endocrine Zone
Parker Willmon
Wilson, Gregory
University of Cincinnati College of Medicine, Department of Surgery
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Gregory Wilson
Winchester, David
North Shore University Health System
33: Validated Predictive Model for Prognosis and Treatment of Papillary Thyroid Carcinoma
Location:Ballroom A
David Winchester
Winer, Leah
Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, USA
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Leah Winer
Winslow, Emily
Medstar Georgetwon
Surg Onc
Location:SSO HUB Theater
Emily Winslow
Winter, Jordan
University Hospitals
98: Disparities in Receipt of Complex GI Cancer Surgery at a Small Geographic Scale
Location:Ballroom A
Jordan Winter
Wise-Draper, Trisha
University of Cincinnati
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Trisha Wise-Draper
Witmer, Hunter D.
Department of Surgery, Section of General Surgery and Surgical Oncology, University of Chicago Medical Center
P53: Therapeutic Implications of Germline Testing in Peritoneal Mesothelioma
Location:SSO HUB: Rare/Metastatic Cancers Zone
Hunter D. Witmer
Witt, Russell
University of Texas MD Anderson Cancer Center
95: Cancer Testis Antigen and Interleukin Expression Correlates with Survival in Small Bowel Neuroendocrine Tumors
Location:Ballroom A
Russell Witt
Woldesenbet, Selamawit
Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
80: Disparities in Socioeconomic Mediation of Racial Segregation in Hepatopancreaticobiliary Cancer
Location:Veterans Memorial Auditorium
Selamawit Woldesenbet
Wolfgang, Christopher
NYU Grossman School of Medicine
Pancreatic Adenocarcinoma
Location:Ballroom A
Christopher Wolfgang
Q & A and Panel Discussion
Location:Ballroom A
Christopher Wolfgang
Wong, Jasmine
Department of Surgery, University of California, San Francisco
4: Germline Genetic Mutations in a Prospective Multi-Center Cohort of 241 Phyllodes Tumors; Time to Expand Testing Criteria
Location:Veterans Memorial Auditorium
Jasmine Wong
Wong, Paul
University of California, San Francisco
25: Combination Immunotherapy with Oncolytic Virus Induces Immunogenic Cell Death and T-cell Proliferation in Colon Cancer
Location:Ballroom C
Paul Wong
Wong, Sandra
Dartmouth-Hitchcock, Geisel School of Medicine at Dartmouth
Between Patient and Policy Maker - What We Can do to Build Global Capacity for Cancer Surgery
Location:Ballroom A
Sandra Wong
Plenary Session 1
Location:Veterans Memorial Auditorium
Sandra Wong
Welcome to SSO 2023
Location:Veterans Memorial Auditorium
Sandra Wong
Wong, Stephanie
McGill Medical School
P12: Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast Conserving Surgery After Neoadjuvant Chemotherapy
Location:SSO HUB: Breast & Endocrine Zone
Stephanie Wong
Woo, Yanghee
CITY OF HOPE CANCER CENTER
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Yanghee Woo
P78: Pilot Study of a Telehealth Intervention for Self-Management of Eating after Gastroesophageal Cancer Surgery
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Yanghee Woo
Working Group, The ISPY2 Surgical
multiple organizations
3: Changes in axillary surgical management over 10 years – report on > 1400 breast cancer patients treated with neoadjuvant chemotherapy on I-SPY2
Location:Veterans Memorial Auditorium
The ISPY2 Surgical Working Group
Wright, Gerald
Spectrum Health
53: Surgical Outcomes of SWOG1801: Neoadjuvant/adjuvant versus adjuvant pembrolizumab for resectable stage III-IV melanoma
Location:Veterans Memorial Auditorium
Gerald Wright
Wu, Abraham
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center
21: Organ Preservation, Compliance and Toxicity in Rectal Cancer Patients Treated with Total Neoadjuvant Therapy: A Post Hoc Analysis of the of the OPRA Phase II Trial
Location:Ballroom C
Abraham Wu
Wu, Erik
Northwestern University - Feinberg School of Medicine
P68: The Impact of Digital Inequities on Gastrointestinal Cancer Disparities in the US
Location:SSO HUB: Rare/Metastatic Cancers Zone
Erik Wu
Wu, Michael
SWOG Statistics and Data Management Center and Fred Hutchinson Cancer Research Center, Seattle, WA, USA
57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations
Location:Veterans Memorial Auditorium
Michael Wu
Wu, Sharon
Caris Life Sciences
P7: Genomic characterization of breast cancer metastases reveals differences in rates of PIK3CA mutation across metastatic sites and worse survival in patients with concurrent CDH1 mutation treated with PI3K inhibitor
Location:SSO HUB: Breast & Endocrine Zone
Sharon Wu
Wu, Xiao
Iovance Biotherapeutics, Inc., San Carlos, CA, USA
64: Lifileucel TIL Cell Therapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors (ICI) and Targeted Therapy: Tumor Tissue Procurement Data from the C-144-01 Study
Location:Veterans Memorial Auditorium
Xiao Wu
Wu, Zhanhong
University of North Carolina
29: Development of a novel PET agent for parathyroid imaging targeting the Calcium-Sensing Receptor (CaSR)
Location:Ballroom A
Zhanhong Wu
Back to Top
